Skip to content
Quebec News Tribune – Lifestyle
Author:
Allogene Therapeutics, Inc.
Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Solid Tumors
July 15, 2026
Allogene Therapeutics Announces Planned CEO Succession
May 28, 2026
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
May 26, 2026
←
Previous Page
1
2